Victory Capital Management Inc Satsuma Pharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
$16.01 - $34.69 $17,306 - $37,499
-1,081 Closed
0 $0
Q1 2020

May 04, 2020
BUY
$14.53 - $30.69 $944 - $1,994
65 Added 6.4%
1,081 $23,000
Q4 2019

Feb 04, 2020
BUY
$9.32 - $19.68 $9,469 - $19,994
1,016 New
1,016 $25,000

About Satsuma Pharmaceuticals, Inc.

STSA Quotes by TradingView
  • Ticker STSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,587,500
  • Description
  • Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...
More about STSA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email